Practice Management Agreements for Rheumatology Clinics: 2026 Guide

What is a Practice Management Agreement?

A Practice Management Agreement (PMA) is a contractual arrangement in which an external management company assumes responsibility for the business operations of a medical practice—including billing, collections, human resources, compliance, facility management, and IT infrastructure—while the practicing physicians retain clinical decision-making authority and often maintain ownership stakes. In a typical rheumatology PMA, the practice pays the management company a percentage of gross revenue, usually ranging from 8% to 15%, in exchange for these services.

Understanding PMA structures is essential for rheumatology practice owners considering clinic partnerships or evaluating whether outsourced management aligns with their financial and clinical goals. This guide walks through the financing implications, cash flow considerations, and strategic decisions rheumatology professionals need to make in 2026.

Why Rheumatology Practices Choose PMAs

Rheumatology practices operate in a complex financial environment. Treating autoimmune diseases—particularly with biologic therapies that carry high acquisition costs and insurance-verification burdens—demands significant administrative resources. Many solo or small-group rheumatologists find that managing billing cycles, prior authorizations, staff scheduling, and regulatory compliance diverts time from clinical work and revenue generation.

PMAs address this by centralizing operations. A management company handles the volume of insurance claims, manages accounts receivable (often a major constraint in rheumatology, where biologic therapies can trigger delayed reimbursements), and ensures the practice stays compliant with evolving healthcare regulations.

Why structure matters for financing: When a rheumatology practice enters a PMA, its revenue is typically guaranteed or predictable—the management company often has a financial stake in practice revenue and implements systems to optimize billing. This stability makes the practice more attractive to lenders considering working capital for rheumatology clinics or medical equipment financing 2026.

Key PMA Components That Affect Financing

Management Fee Structure

The management fee is usually a percentage of gross or net revenue. Some PMAs bundle services; others itemize them. A typical fee schedule includes:

• Base management fee: 8–12% of gross revenue
• Additional costs: IT, compliance reporting, HR support (may add 1–3%)
• Shared savings: If the PMA achieves cost reductions or improves collections, the practice may split those gains

Financing implication: A practice's free cash flow after the management fee is what's available for debt service. Lenders will subtract PMA fees from gross revenue when assessing debt capacity. If a rheumatology practice generates $2 million in annual revenue and pays a 10% fee, lenders model around $1.8 million in usable cash flow.

Revenue Guarantees and Termination Clauses

Some PMAs include revenue guarantees—the management company commits to a minimum performance level. Others impose termination penalties if either party exits early. These clauses directly affect loan qualification.

For lenders: A locked-in PMA with penalties reduces refinancing risk. However, an onerous termination clause may raise concerns. If a practice wants to exit a PMA to fund its own infrastructure, early termination costs can drain capital reserves.

What to watch for: Ensure the PMA contract doesn't prevent you from taking on debt without the management company's consent. Some PMAs require approval for any new obligations over a certain threshold.

Financing Options for PMA Practices

Medical Equipment Financing and Clinic Buildout

Rheumatology clinics invest heavily in diagnostic and treatment infrastructure:

• Ultrasound machines (for joint imaging and guidance)
• Infusion pumps and injection delivery systems
• Electronic health record (EHR) system upgrades
• Facility renovation (separate injection areas, patient lounges)

Medical equipment financing 2026 typically works as follows:

1. Term: 3–7 years, with monthly payments
2. Cost: Monthly payments usually run 2–4% of the equipment's total value
3. Collateral: The equipment itself is collateral; lenders hold a UCC-1 filing
4. Vendor partnerships: Many vendors have preferred lenders and expedite approval

PMA-specific consideration: If the practice doesn't own the building or equipment (the management company or a third party does), your financing options narrow. Ensure your PMA contract clarifies asset ownership and licensing rights. If the PMA owns the ultrasound machines, you may need permission or a separate lease arrangement to add new equipment.

Working Capital Loans for Rheumatology Clinics

Working capital loans address the cash flow gaps inherent in rheumatology:

• Insurance reimbursement delays: Biologic therapy claims can take 30–90 days to process
• Prior authorization backlogs: Patients wait for coverage approval; the practice doesn't invoice until that's resolved
• Staffing costs: Billing specialists, nurses, and injection technicians are paid on payroll regardless of collections timing

Working capital for rheumatology clinics is often structured as:

• Line of credit: Borrow up to a limit; pay interest only on what you use
• Term loan: Fixed amount, repaid over 3–5 years
• Accounts receivable (AR) financing: A lender advances 70–90% of outstanding claims while they're pending

Under a PMA, the management company typically manages AR aging. However, you still bear the ultimate cash flow risk. A working capital line can bridge gaps during high patient volumes or when insurance companies slow payments.

Practice Expansion and Acquisition Financing

If your rheumatology PMA is performing well and you want to open a second location or acquire a neighboring practice, lenders offer:

• SBA 7(a) loans: Up to $5 million, 10-year terms, ~7–9% rates (rates vary by market and lender)
• Bank term loans: Conventional loans from community banks or healthcare-focused lenders
• Seller financing: The practice you're acquiring may carry part of the purchase price

Rheumatology practice acquisition financing considerations:

• Revenue multiples: Rheumatology practices typically sell for 0.8–1.2× annual revenue (EBITDA multiples of 4–6×)
• PMA impact: If the acquired practice is also under a PMA, the acquiring company may negotiate better terms or consolidate management fees
• Due diligence: Lenders will review both your current practice's financial statements and the target practice's historicals

Healthcare Bridge Loans for Physicians

If you're transitioning between financing structures—for example, exiting a PMA and recapitalizing independently—a healthcare bridge loan provides short-term capital (6–18 months) to cover gaps. Once you refinance into permanent financing, the bridge loan is repaid.

Typical scenario: A rheumatology practice wants to buy out its PMA and reclaim operational independence. The practice needs $500,000 to fund the transition (staff hiring, IT buildout, working capital). A bridge loan funds that; once the practice is established on its own and shows 12 months of independent financials, conventional financing replaces the bridge.

Structuring a PMA for Optimal Financing

Best Practices for Loan Qualification

1. Document cash flow clarity

Lenders want to see P&L statements and bank statements for at least 24 months under the PMA. If the management company prepares those statements, request independent verification (e.g., CPA review). Some lenders are skeptical of PMA-generated financials because the management company has an incentive to understate profitability to justify its fee.

2. Review the PMA contract with your accountant and attorney

Before applying for a loan, ensure the PMA:

• Specifies the fee structure clearly
• Does not prohibit you from taking on debt
• Allows you to refinance or restructure if needed
• Clarifies which assets you own vs. the management company owns
• Includes a buyout or exit clause with reasonable terms

3. Build a separate financial cushion

Lenders prefer to see 3–6 months of operating expenses in a reserve account. This demonstrates stability and reduces default risk. Under a PMA, cash flow is more predictable, so demonstrating reserves is easier and strengthens your loan application.

4. Consider the PMA's track record

If you're a newer practice under an established management company, lenders may view this favorably (strong operational support). However, if the management company itself has had regulatory issues, negative publicity, or high practice turnover, lenders will scrutinize the relationship. Be transparent about this.

Comparison: PMA vs. Independent Practice Financing

Factor	PMA Structure	Independent Practice
Monthly management overhead	8–15% of revenue	3–5% (internal staff)
Loan approval timeline	Slightly slower (lenders verify PMA stability)	Faster (fewer variables)
Interest rates	Typically 1–2% higher (risk premium for PMA dependency)	Standard market rates
Debt capacity	Lower (PMA fees reduce free cash flow)	Higher (lower overhead)
Operational flexibility	Limited (PMA controls billing, HR, IT)	Full control
Best for	Practices wanting to minimize non-clinical work	Practices with strong operational leadership

Working with Lenders: Key Questions

When shopping for practice expansion loans or working capital, ask prospective lenders:

1. Do you have experience lending to rheumatology practices under PMAs? Some healthcare lenders specialize in this; others avoid it. Experience matters.

2. What documentation do you need from the PMA? Request a copy of the management agreement (redacted for confidentiality if needed), the most recent P&L, and bank statements.

3. What are your debt-to-income requirements for PMA practices? Some lenders limit debt to 4× EBITDA for PMA practices vs. 5–6× for independent practices. Understand their ratio before applying.

4. How do you treat PMA fees in your cash flow analysis? This varies significantly. Some lenders deduct the full fee; others adjust for expected savings if the practice later becomes independent.

5. What's your rate and term for a 5-year equipment loan in my state? This gives you a concrete anchor before formal application.

Tax Deductions and Financial Planning for PMA Practices

Understanding tax deductions for medical expenses 2026 is critical for rheumatology practice owners.

Business Entity Structure

Your tax liability and deduction options depend on your business entity:

• S-corp or C-corp: You deduct PMA fees as a business expense. Remaining profits are subject to corporate tax (C-corp) or pass through to personal returns (S-corp).
• LLC taxed as partnership: PMA fees are deductible; profits pass through. You owe self-employment tax on your share.
• Sole proprietorship: All PMA fees and practice expenses are deductible on Schedule C; income is subject to self-employment tax.

Recommendation: Most rheumatology practices incorporate as an S-corp or LLC to reduce self-employment taxes and enable deductions for reasonable salaries to yourself as an employee.

Deductible PMA Costs

• Management fee: Fully deductible as a business expense
• Shared IT and compliance costs passed through by the PMA: Deductible
• Staff hired by the PMA on behalf of the practice: Deductible via the management fee

Non-Deductible or Limited Items

• Loan interest above certain thresholds may be subject to capitalization rules (consult your CPA)
• Equipment purchases are depreciated over years (not deducted in year 1), except under Section 179 expensing or bonus depreciation (rules change by year)

2026 note: Tax law changes frequently. Section 179 expensing limits, bonus depreciation schedules, and passive loss rules should be reviewed with a CPA who specializes in healthcare.

Hidden Costs and Risks

Termination Costs

PMAs often impose penalties for early exit. These can range from 6 months of management fees to 10–20% of annual revenue. If you plan to refinance or restructure, budget for potential termination costs when sizing your loan request.

Fee Creep

Watch for management fees that increase faster than inflation. Some PMAs include escalation clauses (e.g., +3% annually). Over a decade, this erodes profitability. Review fee escalation caps before signing.

Operational Risks

If the management company faces financial distress, regulatory action, or closure, your practice could be disrupted. Verify the PMA company's financial stability and ask about continuity plans.

Regulatory Changes

Antikickback statutes, Stark law, and state medical practice regulations affect PMA legality and structure. A PMA that complies in 2026 may not in 2027 if regulations shift. Work with healthcare legal counsel to stay current.

Bottom Line

Practice Management Agreements offer rheumatology practices operational efficiency and financial stability—advantages that can strengthen loan applications for working capital for rheumatology clinics, medical equipment financing 2026, or practice expansion. However, PMAs require careful contract review, transparent cash flow documentation, and alignment with your long-term financial strategy. Before signing a PMA or taking on debt within one, consult with a healthcare accountant and attorney to ensure the structure supports your goals and doesn't create hidden liabilities.

Evaluate whether a PMA or independent operation better suits your practice's size, clinical focus, and risk tolerance. The financing and structuring decisions you make now will shape your practice's flexibility and profitability for years to come.

If you're considering a PMA or exploring best medical business loans 2026, request quotes from lenders experienced in healthcare practice financing and have a CPA review your financial projections.

Disclosures

This content is for educational purposes only and is not financial advice. rheumaevidence1.com may receive compensation from partner lenders, which may influence which products are featured. Rates, terms, and availability vary by lender and applicant qualifications.